Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Joint Juice is a consumer healthcare brand focused on liquid joint health supplements. Founded by orthopedic surgeon Dr. Kevin Stone, the company developed a line of functional beverages containing glucosamine and chondroitin to support joint health and mobility. The products are marketed as a convenient alternative to traditional supplement pills for active individuals and those suffering from joint discomfort. The company was acquired by Premier Nutrition in 2011 and is currently part of the Post Holdings portfolio. Its flagship product is a 25-calorie drink supplement designed for daily consumption to maintain cartilage and joint function.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Joint Juice.